Aortech International PLC
4 July 2001
AORTECH INTERNATIONAL PLC
AGM Statement
At the Annual General Meeting of Aortech International plc, the Scottish-based
developer and manufacturer of cardio-vascular devices and biomaterials, held
today, the Chairman Gordon Wright made the following comments:
'The year has seen continued growth in all of our technologies although it has
been disappointing as regards our share price.
'The underlying heart valve business continues to grow whilst all development
projects remain on schedule and in line with budget. TruCOMMS has been
launched in the USA and has received an encouraging response. We have recently
announced the appointment of Dennis Hurlebaus as Vice President of Sales in
the USA and Dennis's wealth of experience within the Critical Care environment
will, I am confident, deliver sales growth of TruCCOMS in the USA.
'In Europe and the Middle East we have appointed Becton Dickinson to
distribute TruCOMMS and this should enable AorTech to achieve faster sales
growth in this area.
'The development programme for the new heart valve remains on schedule and it
will be entering regulatory testing in August, prior to clinical trials. All
papers presented to date support the Board's view regarding the potential of
this product.
'The continued positive results on the use of Elast-Eon as the material for
the new heart valve demonstrates the unique properties of the material and we
remain confident that further licence agreements will be signed during the
current year.
'In addition to the £20 million fund raising in April we have subsequently
raised an additional £6 million and as a result we have sufficient funds to
cover the ongoing development and commercialisation costs for over two years.
'Overall the Company is performing well and we are confident that our new
products recently brought to the market and the products under development
will meet expectations. We have extended and enhanced our development and
production facilities and have continued to attract high calibre staff. The
Group continues to offer excellent prospects as we continue to develop and
commercialise our unique range of products.'
4 July 2001
ENQUIRIES:
AorTech International plc Tel: 01698 746699
Eddie McDaid, Chief Executive Officer
College Hill Tel: 020 7457 2020
Michael Padley
Nicholas Nelson
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.